Head of Investor Relations
CFO
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
The company reported in an 8-K filed August 5, 2025 that Scott Galovan was appointed Senior Vice President, Chief Financial Officer, effective August 1, 2025. The proxy statement of the company reports total compensation of $2,039,138 for Scott Galovan in fiscal 2025, including a base salary of $392,857. Disclosed compensation is on record for 3 fiscal years. Scott Galovan has spoken on 5 earnings calls across 1 company, most recently on February 24, 2026.
“On August 1, 2025, the Company appointed Scott Galovan to serve as the Company's Senior Vice President, Chief Financial Officer, effective August 1, 2025.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Organization not stated
CFO
SEC 8-K
2025-08-01–present
Organization not stated
Head of Investor Relations
Source not stated
Recorded roles and call appearances connecting this person to public companies.
Company
Head of Investor Relations, CFO
2025-08-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | — | Chief Financial Officer | $392,857 | $2,039,138 |
| 2024 | — | Chief Financial Officer | $341,000 | $1,073,344 |
| 2023 | — | Chief Financial Officer | $325,000 | $881,210 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
Avanos Medical, Inc. Q4 FY2025 Earnings Call
Avanos Medical, Inc. Q3 FY2025 Earnings Call
Avanos Medical, Inc. Q2 FY2025 Earnings Call
Avanos Medical, Inc. Q1 FY2022 Earnings Call
Avanos Medical, Inc. Q4 FY2021 Earnings Call
